Key facts
- Wegovy remains the leading GLP-1 pill for weight loss in the US.
- Foundayo, a competing GLP-1 pill from Eli Lilly, has been launched.
- Wegovy continues to be a preferred choice for Americans seeking weight loss treatments.
Wegovy continues to hold its position as the leading GLP-1 pill in the market for weight loss treatments in the United States. This sustained dominance comes even after the introduction of Foundayo, a competing GLP-1 pill developed by Eli Lilly. Despite the new entrant, Wegovy remains a top choice for Americans seeking to lose weight.
